Compare MOB & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOB | BTMD |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.0M | 71.0M |
| IPO Year | N/A | 2021 |
| Metric | MOB | BTMD |
|---|---|---|
| Price | $5.54 | $2.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $10.00 | $2.83 |
| AVG Volume (30 Days) | ★ 214.7K | 196.7K |
| Earning Date | 03-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $150.10 | $6.58 |
| P/E Ratio | ★ N/A | $36.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.43 | $1.27 |
| 52 Week High | $11.01 | $4.75 |
| Indicator | MOB | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 51.17 |
| Support Level | $5.11 | $1.97 |
| Resistance Level | $6.15 | $2.79 |
| Average True Range (ATR) | 0.67 | 0.16 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 3.86 | 46.90 |
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.